ImmunityBio, Inc. approved discretionary cash bonuses for its named executive officers based on their performance in 2023, with the bonuses to be paid on March 15, 2024. The company also granted option awards and restricted stock units to the officers under its Long-Term Incentive Program, with vesting over 3 years. Additionally, the company approved a new Code of Business Conduct and Ethics.